Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by Prelude Capital Management LLC

Prelude Capital Management LLC lowered its stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 6.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,365 shares of the company’s stock after selling 1,200 shares during the period. Prelude Capital Management […]

Related Keywords

United States ,Ohio ,America ,American ,Elizabeth Yeu Lin ,William Blair ,Aziz Mottiwala ,Group Plc ,American International Group Inc ,Prelude Capital Management ,News Ratings For Tarsus Pharmaceuticals Daily ,Tarsus Pharmaceuticals Profile ,Barclays Plc ,Exchange Commission ,Quarter For Tarsus Pharmaceuticals ,Tarsus Pharmaceuticals ,Nasdaq ,Tarsus Pharmaceuticals Trading ,Tarsus Pharmaceuticals Inc ,Free Report ,Capital Management ,Employees Retirement System ,General Group Plc ,American International Group ,International Group ,Director Elizabeth Yeu Lin ,Get Free Report ,Visit Holdingschannel ,Tarsus Pharmaceuticals Daily ,Nasdaq Tars ,Stars ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,